Presents author's opinion on biotechnology investments. Initial public offerings (IPOs) as financing events for companies; Risk taken by venture capitalists (VCs) and investment of clients' money; Occurrence of financial events at times of maximum market enthusiasm or maximum company desperation, both usually being a disaster for investors; Source of finding a good IPO.